Galvanize Therapeutics · Series D
Designing pulsed electric field energy devices to unlock the body's natural responses for disease treatment and function restoration.
Amount
$130M
Round
Series D
Valuation
—
Announced
May 2023
Investors
Lead investor
HealthQuest CapitalNotes
auto-discovered via firecrawl